[Clinical Characteristics and Prognosis of Myelodysplastic Syndromes Patients with RUNX1 Gene Mutation].

Yi ChenYue-Ru JiJing-Yi ZhangWei-Wei QinCang-Chun LiuLi LiuXue-Qian Yan

Published in: Zhongguo shi yan xue ye xue za zhi (2024)

gene mutation is an adverse prognostic factor in MDS patients, especially in the IPSS-M prognosis stratification group of low-risk, medium-low risk, medium-high risk and WHO classification of early patients.

Keyphrases

prognostic factors
end stage renal disease
newly diagnosed
ejection fraction
emergency department
transcription factor
patient reported